Abstract
Poly- and monoclonal antibody-based (PcAb and mAb) sandwich ELISA formats were developed to detect tropomyosin, a major crustacean allergen. Their performance was accessed by testing crustacean residue in commercial processed and model foods. Results obtained showed the constructed mAb ELISA have lower LOD (0.004 mg/kg) and LOQ (0.006 mg/kg), and higher specificity for crustacean tropomyosin than the PcAb ELISA (LOD: 0.008 mg/kg and LOQ: 0.01 mg/kg). Despite this, the PcAb ELISA system with fewer matrix interferences could discriminate against all commercial foods on the label and show higher tropomyosin recovery than the same positive samples based on a mAb ELISA test. Additionally, both ELISA systems possess adequate repeatability and precision, and can detect as low levels as 0.01% and 0.05% of incurred shrimp powder in cookies and sausages, respectively. Nevertheless, mAb ELISA system shows lower tropomyosin recovery in the same incurred foods, and fish sauce even when supplemented with 5% shrimp powder addition could not be detected by the mAb ELISA test. These findings indicated that the recovery of tropomyosin decreased with the intensity of thermal processing applied to food, while PcAb ELISA showed better matrix-tolerance and detectability in processed foods.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.